Filing Details
- Accession Number:
- 0001209191-18-060457
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-30 18:33:05
- Reporting Period:
- 2018-11-30
- Accepted Time:
- 2018-11-30 18:33:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1408920 | T Joseph Kennedy | C/O Amarin Pharma, Inc. 1430 Route 206 Bedminster NJ 07921 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-11-30 | 1,953 | $1.02 | 219,887 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2018-11-30 | 2,604 | $1.40 | 222,491 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2018-11-30 | 18,749 | $2.50 | 241,240 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2018-11-30 | 23,306 | $17.81 | 217,934 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-11-30 | 1,953 | $0.00 | 1,953 | $1.02 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-11-30 | 2,604 | $0.00 | 2,604 | $1.40 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-11-30 | 18,749 | $0.00 | 18,749 | $2.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,906 | 2025-02-01 | No | 4 | M | Direct | |
| 36,458 | 2026-01-31 | No | 4 | M | Direct | |
| 131,261 | 2025-07-06 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- Please see the section titled "Remarks" below for additional information.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.24 to $18.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 28, 2015.
- On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on February 29, 2016.
- On July 6, 2015, the Reporting Person was granted an option to purchase 900,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on July 31, 2015.
Billionaire Hedge Funds
